It seems this deputy assistant administrator at the DEA believes that Adderall is basically street meth and, well, someone with that level of ignorance about pharmacology should simply not be employed by the DEA or any other drug-regulating agency.
https://www.bloomberg.com/news/articles/2024-04-19/adderall-abuse-risks-becoming-another-opioid-crisis-dea-says?utm_medium=social&utm_source=bluesky&utm_content=business
Conversation
Notices
-
Embed this notice
Max Kennerly (maxkennerly@mstdn.social)'s status on Saturday, 20-Apr-2024 02:27:48 JST Max Kennerly - GreenSkyOverMe (Monika) repeated this.
-
Embed this notice
Max Kennerly (maxkennerly@mstdn.social)'s status on Saturday, 20-Apr-2024 03:35:09 JST Max Kennerly These similarities apply just as much to GLP-1s. There's certainly more aggressive competition among drugmakers to produce and market GLP-1s, whereas the bulk of ADHD drugs are low-profit generics.
So are we going to arbitrarily limit them too, or just ADHD drugs?
In conversation permalink Attachments